期刊文献+

熔融法制备非诺贝特固体分散体及体外溶出研究 被引量:6

Preparation of Solid Dispersion of Fenofibrate by Melting Method and Its Dissolution Rate
下载PDF
导出
摘要 目的:制备非诺贝特固体分散体。方法:采用熔融法制备,考察药物和载体的比例、混合温度、冷却温度对溶出率的影响,比较固体分散体和物理混合物的溶出率的区别。结果:药物和载体比例达到1∶2时,载体的量足够使药物分散均匀;混合温度对溶出率影响较大;冷却温度对溶出率影响不大。与物理混合物相比,固体分散体将非诺贝特的溶出率显著提高。结论:非诺贝特固体分散体提高了非诺贝特的体外溶出率。 Objective:To prepare solid dispersion of fenofibrate.Methods:Melting method was adopted to prepare solid dispersion.The influences of the ratio of the drug to carrier,mixing temperature and cooling temperature on the dissolution of drug were investigated.The differences among the dissolutions of fenofibrate,physical mixture and solid dispersion were explored.Results:When the ratio of the drug to carrier rose to 1∶2,the amount of the carrier was enough to distribute the drug evenly.Cooling temperature had little influence on the dissolution of drugs while mixing temperature had strong influence on the dissolution of drugs.The in vitro test showed that dissolution rate of the prepared solid dispersion was faster than that of fenofibrate and physical mixture.As compared with physical mixture,the dissolution rate of fenofibrate was significantly improved by solid dispersion.Conclusion:Solid dispersion with melting improves the in vitro dissolution rate of fenofibrate.
出处 《药学与临床研究》 2014年第2期109-111,共3页 Pharmaceutical and Clinical Research
关键词 非诺贝特 共聚维酮(S630) 固体分散体 溶出率 Fenofibrate PVP-VA(S630) Solid dispersion Dissolution rate
  • 相关文献

参考文献3

  • 1李满,满世伟,金丽丹.非诺贝特降脂特点简介[J].实用药物与临床,2005,8(S1):35-36. 被引量:7
  • 2Vogt M, Kunath K, Dressman JB. Dissolution enhance- ment of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations [J]. Eur J Pharm Biopharm, 2008, 68(2): 283-8.
  • 3Van den Mooter G. The use of amorphous solid dis- persions: A formulation strategy to overcome poor solu- bility and dissolution rate[J]. Drug Discov Today Tech- nol, 2012, 9(2): e79-85.

共引文献6

同被引文献70

  • 1郑杨,张志丽,王立红,礼彤,郭永学,周丽莉.非诺贝特固体分散体制备工艺研究及比较[J].中国药剂学杂志(网络版),2012(2):26-34. 被引量:10
  • 2杨仲文,代东梅,程天贵,杨传珏.非诺贝特咀嚼片的溶出度考察[J].中国医院药学杂志,2005,25(6):530-532. 被引量:2
  • 3万江华.粉防己碱的药理与临床研究进展[J].中国医院药学杂志,1995,15(5):222-224. 被引量:8
  • 4王文英,李祥华.粉防己碱的心血管药理研究进展[J].时珍国医国药,2005,16(10):1039-1041. 被引量:9
  • 5田吉,何兵,邱华荣.防己渗漉工艺的优选研究[J].时珍国医国药,2007,18(12):3082-3083. 被引量:6
  • 6Moroni A. A novel copovidone binder for dry granulation anddirect compression tabletting [J]. Pharm Tech, 2001, 24(9):8-12.
  • 7Kolter K, Flick D. Structure and dry binding activity ofdifferent polymers, including Kollidon VA 64 [J]. Drug DevInd Pharm, 2000, 26(11): 1159-1165.
  • 8Maniruzzaman M, Rana MM, Boateng JS, et al. Dissolutionenhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers [J]. Drug Dev IndPharm, 2013, 39(2): 218-227.
  • 9Mahmah 0, Tabbakh R, Kelly A,et al. A comparative studyof the effect of spray drying and hot-melt extrusion onthe properties of amorphous solid dispersions containingfelodipine [J]. J Pharm Pharmacol’ 2014, 66 (2): 275-284.
  • 10Leuner C, Dressman J. Improving drug solubility for oraldelivery using solid dispersions [J]. Eur J Pharm Biopharm,2000,50(1):47-60.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部